Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Cancer Letters|June 25, 2010
Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cellsEun Uk Jung, Jung-Hwan Yoon, Youn-Jae Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 25, 2016
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL studyJia-Horng Kao, Youn-Jae Lee, Jeong Heo, et al.
Clinical and Molecular Hepatology|November 4, 2015
Comparison and analysis of the prevalence of hepatitis C virus infection by region in the Republic of Korea during 2005-2012Hae-Sook Shon, Hwa Young Choi, Jang Rak Kim, et al.
Gut and Liver|August 12, 2015
Risk Factors for Hepatitis C Virus (HCV) Infection in Areas with a High Prevalence of HCV in the Republic of Korea in 2013Hae-Sook Sohn, Jang Rak Kim, So Yeon Ryu, et al.
Digestive Diseases and Sciences|November 19, 2010
Development and validation of a model to predict advanced fibrosis in chronic hepatitis B virus-infected patients with high viral load and normal or minimally raised ALTSeung Ha Park, Chang Hoon Kim, Dong Joon Kim, et al.
Hepatology International|June 14, 2015
A review of the burden of hepatitis C virus infection in China, Japan, South Korea and TaiwanHeather Bennett, Nathalie Waser, Karissa Johnston, et al.
Clinical and Molecular Hepatology|December 31, 2014
Geographic differences in the epidemiological features of HCV infection in KoreaKyung-Ah Kim, Sook-Hyang Jeong, Eun Sun Jang, et al.
The Korean Journal of Hepatology|September 26, 2008
[Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection]Myoung Joo Kang, Eun Uk Jung, Sang Won Park, et al.
Drug Design, Development and Therapy|November 30, 2017
Baracle® vs Baraclude® for 48 weeks in patients with treatment-naïve chronic hepatitis B: a comparison of efficacy and safetyDo Young Kim, Ju Hyun Kim, Won Young Tak, et al.
Clinical and Molecular Hepatology|May 29, 2019
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infectionYoun Jae Lee, Jeong Heo, Do Young Kim, et al.
Pageof 8